• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌细胞衍生的淋巴毒素通过诱导成纤维细胞中 CXCL11 的表达来介导人卵巢癌中的肿瘤-基质相互作用。

Cancer cell-derived lymphotoxin mediates reciprocal tumour-stromal interactions in human ovarian cancer by inducing CXCL11 in fibroblasts.

机构信息

Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong, China.

出版信息

J Pathol. 2014 Jan;232(1):43-56. doi: 10.1002/path.4258.

DOI:10.1002/path.4258
PMID:24014111
Abstract

We have investigated the role of cytokine lymphotoxin in tumour-stromal interactions in human ovarian cancer. We found that lymphotoxin overexpression is commonly shared by the cancer cells of various ovarian cancer subtypes, and lymphotoxin-beta receptor (LTBR) is expressed ubiquitously in both the cancer cells and cancer-associated fibroblasts (CAFs). In monoculture, we showed that ovarian cancer cells are not the major lymphotoxin-responsive cells. On the other hand, our co-culture studies demonstrated that the cancer cell-derived lymphotoxin induces chemokine expression in stromal fibroblasts through LTBR-NF-κB signalling. Amongst the chemokines being produced, we found that fibroblast-secreted CXCL11 promotes proliferation and migration of ovarian cancer cells via the chemokine receptor CXCR3. CXCL11 is highly expressed in CAFs in ovarian cancer biopsies, while CXCR3 is found in malignant cells in primary ovarian tumours. Additionally, the overexpression of CXCR3 is significantly associated with the tumour grade and lymph node metastasis of ovarian cancer, further supporting the role of CXCR3, which interacts with CXCL11, in promoting growth and metastasis of human ovarian cancer. Taken together, these results demonstrated that cancer-cell-derived lymphotoxin mediates reciprocal tumour-stromal interactions in human ovarian cancer by inducing CXCL11 in fibroblasts. Our findings suggest that lymphotoxin-LTBR and CXCL11-CXCR3 signalling represent therapeutic targets in ovarian cancer.

摘要

我们研究了细胞因子淋巴毒素在人类卵巢癌肿瘤-基质相互作用中的作用。我们发现,淋巴毒素过表达在各种卵巢癌亚型的癌细胞中普遍存在,淋巴毒素-β受体(LTBR)在癌细胞和癌相关成纤维细胞(CAFs)中广泛表达。在单核培养中,我们表明卵巢癌细胞不是淋巴毒素主要反应细胞。另一方面,我们的共培养研究表明,癌细胞衍生的淋巴毒素通过 LTBR-NF-κB 信号诱导基质成纤维细胞中趋化因子的表达。在所产生的趋化因子中,我们发现成纤维细胞分泌的 CXCL11 通过趋化因子受体 CXCR3 促进卵巢癌细胞的增殖和迁移。在卵巢癌活检中,CAFs 中高表达 CXCL11,而原发性卵巢肿瘤中的恶性细胞中存在 CXCR3。此外,CXCR3 的过度表达与卵巢癌的肿瘤分级和淋巴结转移显著相关,进一步支持了 CXCR3 与 CXCL11 相互作用在促进人类卵巢癌生长和转移中的作用。综上所述,这些结果表明,癌细胞衍生的淋巴毒素通过诱导成纤维细胞中的 CXCL11 介导人类卵巢癌中的肿瘤-基质相互作用。我们的发现表明淋巴毒素-LTBR 和 CXCL11-CXCR3 信号代表卵巢癌的治疗靶点。

相似文献

1
Cancer cell-derived lymphotoxin mediates reciprocal tumour-stromal interactions in human ovarian cancer by inducing CXCL11 in fibroblasts.癌细胞衍生的淋巴毒素通过诱导成纤维细胞中 CXCL11 的表达来介导人卵巢癌中的肿瘤-基质相互作用。
J Pathol. 2014 Jan;232(1):43-56. doi: 10.1002/path.4258.
2
Oxaliplatin inhibits colorectal cancer progression by inhibiting CXCL11 secreted by cancer-associated fibroblasts and the CXCR3/PI3K/AKT pathway.奥沙利铂通过抑制癌症相关成纤维细胞分泌的CXCL11以及CXCR3/PI3K/AKT途径来抑制结直肠癌进展。
Clin Transl Oncol. 2023 Jan;25(1):160-172. doi: 10.1007/s12094-022-02922-8. Epub 2022 Sep 21.
3
CXCL11-CXCR3 Axis Mediates Tumor Lymphatic Cross Talk and Inflammation-Induced Tumor, Promoting Pathways in Head and Neck Cancers.CXCL11-CXCR3 轴介导肿瘤淋巴管相互作用和炎症诱导的肿瘤促进途径在头颈部癌症中的作用。
Am J Pathol. 2020 Apr;190(4):900-915. doi: 10.1016/j.ajpath.2019.12.004. Epub 2020 Feb 5.
4
CXCL11 promotes tumor progression by the biased use of the chemokine receptors CXCR3 and CXCR7.CXCL11 通过偏倚性地利用趋化因子受体 CXCR3 和 CXCR7 促进肿瘤进展。
Cytokine. 2020 Jan;125:154809. doi: 10.1016/j.cyto.2019.154809. Epub 2019 Aug 19.
5
Feedback control of the CXCR7/CXCL11 chemokine axis by estrogen receptor α in ovarian cancer.卵巢癌细胞中雌激素受体 α 对 CXCR7/CXCL11 趋化因子轴的反馈控制。
Mol Oncol. 2018 Oct;12(10):1689-1705. doi: 10.1002/1878-0261.12362. Epub 2018 Aug 23.
6
The CXCR3-CXCL11 signaling axis mediates macrophage recruitment and dissemination of mycobacterial infection.CXCR3-CXCL11信号轴介导巨噬细胞募集和分枝杆菌感染的传播。
Dis Model Mech. 2015 Mar;8(3):253-69. doi: 10.1242/dmm.017756. Epub 2015 Jan 8.
7
Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4, CD8 T cells, and M1 macrophages.计划中的缺陷:miR-34a-5p 通过调节 CD4、CD8 T 细胞和 M1 巨噬细胞中的 CXCL10/CXCL11/CXCR3 轴来影响趋化因子信号。
J Immunother Cancer. 2020 Nov;8(2). doi: 10.1136/jitc-2020-001617.
8
TNFα-exposed bone marrow-derived mesenchymal stem cells promote locomotion of MDA-MB-231 breast cancer cells through transcriptional activation of CXCR3 ligand chemokines.TNFα 暴露的骨髓间充质干细胞通过转录激活 CXCR3 配体趋化因子促进 MDA-MB-231 乳腺癌细胞的迁移。
J Biol Chem. 2010 Oct 1;285(40):30731-40. doi: 10.1074/jbc.M110.128124. Epub 2010 Jul 22.
9
Lymphotoxin-β receptor in microenvironmental cells promotes the development of T-cell acute lymphoblastic leukaemia with cortical/mature immunophenotype.微环境细胞中的淋巴毒素-β 受体促进具有皮质/成熟免疫表型的 T 细胞急性淋巴细胞白血病的发展。
Br J Haematol. 2015 Dec;171(5):736-51. doi: 10.1111/bjh.13760. Epub 2015 Oct 12.
10
Interferons induce CXCR3-cognate chemokine production by human metastatic melanoma.干扰素诱导人转移性黑色素瘤产生 CXCR3 同源趋化因子。
J Immunother. 2010 Nov-Dec;33(9):965-74. doi: 10.1097/CJI.0b013e3181fb045d.

引用本文的文献

1
Analysis of the correlation between inflammatory cytokines and glioblastoma: A Mendelian randomization study.炎症细胞因子与胶质母细胞瘤之间的相关性分析:一项孟德尔随机化研究。
Medicine (Baltimore). 2025 May 30;104(22):e42137. doi: 10.1097/MD.0000000000042137.
2
Engineered CAF-cancer cell hybrid membrane biomimetic dual-targeted integrated platform for multi-dimensional treatment of ovarian cancer.工程化CAF-癌细胞杂交膜仿生双靶点整合平台用于卵巢癌的多维治疗
J Nanobiotechnology. 2025 Feb 5;23(1):83. doi: 10.1186/s12951-025-03165-9.
3
DFASGCNS: A prognostic model for ovarian cancer prediction based on dual fusion channels and stacked graph convolution.
DFASGCNS:基于双融合通道和堆叠图卷积的卵巢癌预测预后模型。
PLoS One. 2024 Dec 16;19(12):e0315924. doi: 10.1371/journal.pone.0315924. eCollection 2024.
4
Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution.癌症相关成纤维细胞与代谢重编程:揭开肿瘤演进中复杂的串扰。
J Hematol Oncol. 2024 Sep 2;17(1):80. doi: 10.1186/s13045-024-01600-2.
5
Association between inflammatory factors and melanoma: a bidirectional Mendelian randomization study.炎症因子与黑色素瘤的关联:一项双向孟德尔随机化研究。
Cancer Causes Control. 2024 Oct;35(10):1333-1342. doi: 10.1007/s10552-024-01890-4. Epub 2024 Jun 6.
6
Systematic analysis of the prognostic value and immunological function of LTBR in human cancer.系统分析 LTBR 在人类癌症中的预后价值和免疫功能。
Aging (Albany NY). 2024 Jan 3;16(1):129-152. doi: 10.18632/aging.205356.
7
Identification of TRPM2 as a Potential Therapeutic Target Associated with Immune Infiltration: A Comprehensive Pan-Cancer Analysis and Experimental Verification in Ovarian Cancer.鉴定TRPM2作为与免疫浸润相关的潜在治疗靶点:一项全面的泛癌分析及卵巢癌实验验证
Int J Mol Sci. 2023 Jul 25;24(15):11912. doi: 10.3390/ijms241511912.
8
Comprehensive bioinformatic analysis constructs a CXCL model for predicting survival and immunotherapy effectiveness in ovarian cancer.综合生物信息学分析构建了一个用于预测卵巢癌生存率和免疫治疗效果的CXCL模型。
Front Pharmacol. 2023 Mar 9;14:1127557. doi: 10.3389/fphar.2023.1127557. eCollection 2023.
9
Signaling pathways in cancer-associated fibroblasts: recent advances and future perspectives.癌症相关成纤维细胞中的信号通路:最新进展和未来展望。
Cancer Commun (Lond). 2023 Jan;43(1):3-41. doi: 10.1002/cac2.12392. Epub 2022 Nov 24.
10
CXC Chemokine Signaling in Progression of Epithelial Ovarian Cancer: Theranostic Perspectives.CXC 趋化因子信号在卵巢上皮性癌进展中的作用:治疗诊断学展望。
Int J Mol Sci. 2022 Feb 27;23(5):2642. doi: 10.3390/ijms23052642.